SAN MATEO, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (NasdaqGM:PTIE - News) today announced that management is scheduled to present at the following investor conferences:

 * The 17th Annual Credit Suisse Health Care Conference in Phoenix, Arizona
   Thursday, November 13th at 4:00 p.m. Mountain Time

 * The 20th Annual Piper Jaffray Health Care Conference in New York
   Wednesday, December 3rd at 10:00 a.m. Eastern Time

To access a webcast of the live events please visit Pain Therapeutics' web site, http://www.paintrials.com. A replay will also be available for approximately 30 days after each event.

About Pain Therapeutics, Inc.

Pain Therapeutics is a biopharmaceutical company that develops novel drugs. In addition to REMOXY(r), the Company has four drug candidates in clinical programs, including PTI-202, PTI-721, Oxytrex(tm) and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. Pain Therapeutics is also working on a new treatment for patients with hemophilia. The FDA has not yet evaluated the merits, safety or efficacy of the Company's drug candidates. For more information, please visit http://www.paintrials.com.

          Pain Therapeutics, Inc.
          Christi Waarich, Senior Manager of Investor Relations
          650-645-1924
          cwaarich@paintrials.com